tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AMPH Stock Latest News

Amphastar price target lowered to $30 from $34 at Wells Fargo
The FlyAmphastar price target lowered to $30 from $34 at Wells Fargo
4d ago
AMPH
Amphastar reports Q4 EPS 73c, consensus 92c
PremiumThe Fly
Amphastar reports Q4 EPS 73c, consensus 92c
4d ago
AMPH
Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
PremiumThe Fly
Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
7d ago
AMPH
AMPH Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AMPH Upcoming Earnings Report: What to Expect?
7d ago
AMPH
Amphastar Licenses ACTH Analog AMP-110 for North America
PremiumCompany Announcements
Amphastar Licenses ACTH Analog AMP-110 for North America
2M ago
8K
AMPH
Amphastar price target lowered to $30 from $31 at BofA
PremiumThe FlyAmphastar price target lowered to $30 from $31 at BofA
2M ago
AMPH
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
Premium
Ratings
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
3M ago
AMPH
Amphastar announces FDA approval for teriparatide injection
Premium
The Fly
Amphastar announces FDA approval for teriparatide injection
3M ago
AMPH
Amphastar initiated with an Equal Weight at Barclays
PremiumThe Fly
Amphastar initiated with an Equal Weight at Barclays
3M ago
AMPH
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
PremiumCompany Announcements
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
4M ago
AMPH
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
4M ago
AMPH
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
PremiumCompany Announcements
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
4M ago
AMPH
Amphastar reports Q3 adjusted EPS 93c, consensus 83c
PremiumThe FlyAmphastar reports Q3 adjusted EPS 93c, consensus 83c
4M ago
AMPH
AMPH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AMPH Upcoming Earnings Report: What to Expect?
4M ago
AMPH
Amphastar Expands BAQSIMI® Distribution in Asia
Premium
Company Announcements
Amphastar Expands BAQSIMI® Distribution in Asia
4M ago
8K
AMPH
Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target
PremiumRatings
Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target
4M ago
AMPH
Amphastar price target lowered to $31 from $32 at BofA
PremiumThe Fly
Amphastar price target lowered to $31 from $32 at BofA
5M ago
AMPH
Amphastar Signs $2.8M Research Agreement with Hanxin
PremiumCompany Announcements
Amphastar Signs $2.8M Research Agreement with Hanxin
6M ago
8K
AMPH
Amphastar price target raised to $32 from $28 at BofA
PremiumThe Fly
Amphastar price target raised to $32 from $28 at BofA
6M ago
AMPH
Amphastar Pharmaceuticals’ Mixed Earnings Call Highlights
PremiumCompany AnnouncementsAmphastar Pharmaceuticals’ Mixed Earnings Call Highlights
7M ago
AMPH
Amphastar Pharmaceuticals: Strategic Positioning and Robust Pipeline Justify Buy Rating
Premium
Ratings
Amphastar Pharmaceuticals: Strategic Positioning and Robust Pipeline Justify Buy Rating
7M ago
AMPH
Amphastar announced FDA approval of iron sucrose injection
Premium
The Fly
Amphastar announced FDA approval of iron sucrose injection
7M ago
AMPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >